Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10258 | 1014 | 45.6 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SPECIALIZED HYPERTENS GENET | Address | 18 | 89% | 1% | 8 |
2 | HYPERTENS GENET SPECIALIZED | Address | 15 | 82% | 1% | 9 |
3 | BIOMED IL 236 | Address | 9 | 83% | 0% | 5 |
4 | HUMAN NEUROTRANSMITTERS | Address | 6 | 31% | 2% | 17 |
5 | RABBIT MODEL OF OBESITY | Author keyword | 4 | 75% | 0% | 3 |
6 | CARDIOL PULM MED | Address | 4 | 25% | 1% | 13 |
7 | HYPERTENSION OBESITY | Author keyword | 4 | 28% | 1% | 11 |
8 | SELECTIVE LEPTIN RESISTANCE | Author keyword | 3 | 100% | 0% | 3 |
9 | CLINEX | Address | 2 | 67% | 0% | 2 |
10 | FAMILY HISTORY OF OBESITY | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OBESITY RELATED HYPERTENSION | 18 | 36% | 4% | 40 |
2 | DEPENDENT PLATELET AGGREGATION | 11 | 65% | 1% | 11 |
3 | CHRONIC ISCHEMIC INJURY | 9 | 83% | 0% | 5 |
4 | YELLOW OBESE MICE | 9 | 83% | 0% | 5 |
5 | SELECTIVE LEPTIN RESISTANCE | 7 | 48% | 1% | 11 |
6 | BLOOD PRESSURE ELEVATION | 4 | 24% | 1% | 15 |
7 | OBESITY INDUCED HYPERTENSION | 4 | 29% | 1% | 12 |
8 | HYPERLEPTINEMIA | 3 | 18% | 2% | 17 |
9 | II INDUCED VASOCONSTRICTION | 3 | 50% | 0% | 5 |
10 | OBESE RABBITS | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Leptin and coronary heart disease: A systematic review and meta-analysis | 2014 | 10 | 29 | 66% |
Leptin and atherosclerosis | 2006 | 219 | 145 | 47% |
Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins | 2010 | 106 | 30 | 50% |
Leptin resistance - A possible interface of inflammation and metabolism in obesity-related cardiovascular disease | 2008 | 157 | 125 | 32% |
Role of leptin and central nervous system melanocortins in obesity hypertension | 2013 | 15 | 33 | 67% |
Selective leptin resistance revisited | 2013 | 27 | 152 | 41% |
Role of leptin in blood pressure regulation and arterial hypertension | 2006 | 87 | 144 | 67% |
Leptin and Coronary Heart Disease Prospective Study and Systematic Review | 2009 | 72 | 40 | 35% |
Leptin and cardiovascular disease - Response to therapeutic interventions | 2008 | 79 | 114 | 40% |
Leptin, obesity and cardiovascular disease | 2004 | 91 | 72 | 81% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SPECIALIZED HYPERTENS GENET | 18 | 89% | 0.8% | 8 |
2 | HYPERTENS GENET SPECIALIZED | 15 | 82% | 0.9% | 9 |
3 | BIOMED IL 236 | 9 | 83% | 0.5% | 5 |
4 | HUMAN NEUROTRANSMITTERS | 6 | 31% | 1.7% | 17 |
5 | CARDIOL PULM MED | 4 | 25% | 1.3% | 13 |
6 | CLINEX | 2 | 67% | 0.2% | 2 |
7 | SPECIALIZED HYPERTENS | 2 | 67% | 0.2% | 2 |
8 | MISSISSIPPI OBES | 2 | 50% | 0.3% | 3 |
9 | NEUROVASC HYPERTENS KIDNEY DIS | 1 | 17% | 0.8% | 8 |
10 | L20 | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000141630 | LEPTIN//LEPTIN RECEPTOR//OB GENE |
2 | 0.0000128895 | OBESITY CARDIOMYOPATHY//CARDIAC REHABIL CARDIOVASC DIS//OXFORD CLIN CARDIOVASC IL |
3 | 0.0000127170 | OBESITY RELATED GLOMERULOPATHY//SENSOR BIOANALYT SCI//HYPERFILTRATION NEPHROPATHY |
4 | 0.0000117200 | MUSCLE SYMPATHETIC NERVE ACTIVITY//SAHLGREN//EXERCISE SCI HLTH PHYS EDUC |
5 | 0.0000115992 | HYPERINSULINEMIA//SUGAR INDUCED HYPERTENSION//ATHEROSCLEROSIS METAB CLIN NUTR |
6 | 0.0000109938 | RESISTANT HYPERTENSION//RENAL DENERVATION//RENAL SYMPATHETIC DENERVATION |
7 | 0.0000100754 | TELMISARTAN//ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER//CLIN TRIAL MANAGEMENTITABASHI KU |
8 | 0.0000086654 | EPICARDIAL ADIPOSE TISSUE//EPICARDIAL FAT//PERIVASCULAR ADIPOSE TISSUE |
9 | 0.0000086071 | NEIRID//MOL CELLULAR CARDIOL 7//NEIRID NEUROENDOCRINE INTERACT RHEUMATOL IN |
10 | 0.0000070289 | NUTRITIVE FLOW//NON NUTRITIVE FLOW//INSULIN TRANSPORT |